TRCT
LABX

Tower Research Capital (TRC)’s Tradr 2X Long ALAB Daily ETF LABX Stock Holding History

Tower Research Capital (TRC)’s Portfolio LABX Stock Details LABX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-400
Closed -$3.05K – 5739
2025
Q4 		$3.05K Buy
+400
New +$3.58K ﹤0.01% 4433

Other funds holding LABX

Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tower Research Capital (TRC)'s LABX Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Tradr 2X Long ALAB Daily ETF (LABX) in Q1 2026, closing a stake of 400 shares — an estimated $3.05K sold.

Tower Research Capital (TRC) first reported a position in LABX in Q4 2025 and held it in 1 quarter. The position peaked at $3.05K in Q4 2025. 6 funds tracked by Wall St. Rank hold LABX as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Tradr 2X Long ALAB Daily ETF position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 400 Tradr 2X Long ALAB Daily ETF shares in Q1 2026, an estimated $3.05K.
  • Tower Research Capital (TRC) first reported a position in Tradr 2X Long ALAB Daily ETF in Q4 2025 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s Tradr 2X Long ALAB Daily ETF position peaked at $3.05K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Tradr 2X Long ALAB Daily ETF as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.